|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/47 | |
| C07K 14/705 | |||
| A61K 39/00 | |||
| A61P 35/00 | |||
| C07K 14/74 |
| (11) | Number of the document | 2089423 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07827143.4 |
| Date of filing the European patent application | 2007-09-23 | |
| (97) | Date of publication of the European application | 2009-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2007/001168 |
| Date | 2007-09-23 |
| (87) | Number | WO 2008/035350 |
| Date | 2008-03-27 |
| (30) | Number | Date | Country code |
| 846087 P | 2006-09-21 | US |
| (72) |
CARMON, Lior, IL
|
| (73) |
Vaxil Biotherapeutics Ltd.,
Building 13A Weizmann Science Park, 76120 Rehovot,
IL
|
| (54) | ANTIGEN SPECIFIC MULTI EPITOPE VACCINES |
| ANTIGEN SPECIFIC MULTI EPITOPE VACCINES |